Drugging Cancer-Causing KRas: Progress in an Uphill Battle
Cancer Cancer Treatment Ras

Drugging Cancer-Causing KRas: Progress in an Uphill Battle

Dr. Talia Henkle
Dr. Talia Henkle

In 10 seconds?  Scientists have finally figured out how to tackle the KRas protein that is involved in promoting cancer. But much more work needs to be done before patients will broadly benefit.

What's the story? Mutations in the KRas protein (involved in cell growth, maturation, and death) are known to drive growth in many types of cancers, but scientists had deemed KRas ‘undruggable’. Finally, the tide is changing.

Get unlimited access to our 3-min Digests and other premium features

Choose your plan:

Sparrow Unlimited

$19/month
  • Includes a free 7-day trial
  • Weekly Recap email
  • Daily updates with the latest research
  • Unlimited access to all Digests
  • Explore all citations and resources
  • Review learnings with Quick Dive
  • The Sparrow Sessions Podcast
  • No advertisement
  • Cancel anytime

We'll send you a reminder email 3 days before your trial ends.

Start my free trial

Sparrow Unlimited

$99/year
  • Save 56% in one, easy payment
  • Includes a free 7-day trial
  • Weekly Recap email
  • Daily updates with the latest research
  • Unlimited access to all Digests
  • Explore all citations and resources
  • Review learnings with Quick Dive
  • The Sparrow Sessions Podcast
  • No advertisement
  • Cancel anytime

We'll send you a reminder email 3 days before your trial ends.

Start my free trial